DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer.

DNA脱碱基位点可作为合理的治疗靶点，以增强替莫唑胺对MMR功能正常和MMR缺陷型癌症的疗效